The global medical affairs outsourcing market size is expected to reach USD 4.6 billion registering a CAGR of 13.6% from 2023 to 2030. Transformation in the medical education and the rising number of orphan therapies for treatment of rare diseases are some of the key factors propelling the market growth. The pharmaceutical companies are looking for assistance to systematically position the therapeutic outcomes of these therapies in the market. During the year 2021, the Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) approved 50 new molecular entities, of which more than half (26) were orphan drugs. A growing number of orphan drug approvals is expected to drive the global market for medical affairs outsourcing over the forecast period.
Changes in the reimbursement scenario and pricing pressure are expected to increase the adoption of cost-saving measures by the pharmaceutical and medical device companies. This is anticipated to promote off-shoring of medical affairs outsourcing in countries like India and China. Pharmaceutical companies are outsourcing medical affairs services to get high-quality documents, control the R&D cost, and reduce investment costs required to train the medical affairs team. Furthermore, pharmaceutical and medical device companies are outsourcing their medical affairs services to diverge their business activities and manage product life cycles.
In addition, Contract Research Organizations (CROs) offer cost-efficient solutions and compliance with the health authority requirements, thereby propelling market growth. The bio/pharmaceutical outsourcing industry has seen a rise in R&D demand because of the COVID-19 pandemic. This increase in demand, as well as other impacts from the pandemic, such as rising demand for clinical trials and its outsourcing services, have caused some CROs to shift focus and adjust their operations. The pandemic has pushed more pharmaceutical companies and regulators to use new technologies for remote quality audits and inspections, thus driving positive changes in the pharma industry. Also, digitalization has for clinical trials that requires interactions with patient groups, and role in specialty care are expected to become integral to the medical affairs function and reduce the impact of pandemic.
Changes in the reimbursement scenario and pricing pressure are expected to increase the adoption of cost-saving measures by the pharmaceutical and medical device companies. This is anticipated to promote off-shoring of medical affairs outsourcing in countries like India and China. Pharmaceutical companies are outsourcing medical affairs services to get high-quality documents, control the R&D cost, and reduce investment costs required to train the medical affairs team. Furthermore, pharmaceutical and medical device companies are outsourcing their medical affairs services to diverge their business activities and manage product life cycles.
In addition, Contract Research Organizations (CROs) offer cost-efficient solutions and compliance with the health authority requirements, thereby propelling market growth. The bio/pharmaceutical outsourcing industry has seen a rise in R&D demand because of the COVID-19 pandemic. This increase in demand, as well as other impacts from the pandemic, such as rising demand for clinical trials and its outsourcing services, have caused some CROs to shift focus and adjust their operations. The pandemic has pushed more pharmaceutical companies and regulators to use new technologies for remote quality audits and inspections, thus driving positive changes in the pharma industry. Also, digitalization has for clinical trials that requires interactions with patient groups, and role in specialty care are expected to become integral to the medical affairs function and reduce the impact of pandemic.
Medical Affairs Outsourcing market Report Highlights
- The medical writing & publishing segment led the market in 2022 and is expected to witness significant growth over the forecast period, owing to the increasing need for marketable written content to convey medical information to healthcare professionals and patients.
- North America dominated the global market with a share of 34.9% in 2022 owing to the presence of a large number of pharmaceutical and medical devices companies in the region.
- Moreover, the high cost of medical affairs services is a major challenge, which has encouraged various medical device companies in North America to outsource functions to third-party vendors in off-shore locations with a high level of expertise in the domain.
- However, Asia Pacific is anticipated to grow at the fastest CAGR over the forecast period, owing to cost-efficient service offering by the CROs in the region. In addition, improved regulatory framework and availability of a skilled workforce in APAC boosts the market growth.
Table of Contents
Chapter 1 Methodology and Scope1.1 Market Segmentation & Scope
1.1.1 Services
1.1.2 Industry
1.1.3 Regional Scope
1.1.4 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.7 List Of Secondary Sources
1.8 List Of Primary Sources
1.9 List Of Abbreviations
1.10 Objectives
1.10.1 Objective - 1
1.10.2 Objective - 2
1.10.3 Objective - 3
1.10.4 Objective - 4
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
Chapter 3 Medical Affairs Outsourcing Market: Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.1.2 Ancillary market outlook
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.1.1 Increasing number of clinical trials
3.2.1.2 Cost-effectiveness and high quality services offered by CROs
3.2.1.3 Stringent regulatory scenario
3.2.2 Market Restraint Analysis
3.2.2.1 Inability to hire experienced technical staff
3.2.3 Industry Challenges
3.2.3.1 Managing relationships
3.2.4 COVID-19 Impact
3.3 Medical Affairs Outsourcing Market Analysis Tools
3.3.1 Porter’s Five Forces Analysis
3.3.2 PESTEL Analysis
3.3.3 Major Deals & Strategic Alliances Analysis
3.3.3.1 Mergers and Acquisitions
3.3.3.2 Collaboration
3.3.3.3 Product Launch
Chapter 4 Medical Affairs Outsourcing Market: Services Segment Analysis
4.1 Medical Affairs Outsourcings: Market Share Analysis, 2022 & 2030
4.2 Medical Writing & Publishing
4.2.1 Medical writing & publishing market, 2018 - 2030 (USD Million)
4.3 Medical Monitoring
4.3.1 Medical monitoring market, 2018 - 2030 (USD Million)
4.4 Medical Science Liaisons (MSLs)
4.4.1 Medical science liaisons (MSLs) market, 2018 - 2030 (USD Million)
4.5 Medical Information
4.5.1 Medical information market, 2018 - 2030 (USD Million)
4.6 Others
4.6.1 Others market, 2018 - 2030 (USD Million)
Chapter 5 Medical Affairs Outsourcing Market: Industry Segment Analysis
5.1 Medical Affairs Outsourcings: Market Share Analysis, 2022 & 2030
5.2 Pharmaceutical
5.2.1 Pharmaceutical market, 2018 - 2030 (USD Million)
5.3 Biopharmaceutical
5.3.1 Biopharmaceutical market, 2018 - 2030 (USD Million)
5.4 Medical Devices
5.4.1 Medical devices market, 2018 - 2030 (USD Million)
5.4.2 Therapeutic Medical Devices
5.4.2.1 Therapeutic medical devices market, 2018 - 2030 (USD Million)
5.4.3 Diagnostic Medical Devices
5.4.3.1 Diagnostic medical devices market, 2018 - 2030 (USD Million)
Chapter 6 Medical Affairs Outsourcing Market: Regional Analysis
6.1 Medical Affairs Outsourcing: Market Share Analysis, 2022 & 2030
6.2 North America
6.2.1 North America medical affairs outsourcing market, 2018 - 2030 (USD Million)
6.2.2 U.S.
6.2.2.1 U.S. medical affairs outsourcing market, 2018 - 2030 (USD Million)
6.2.3 Canada
6.2.3.1 Canada medical affairs outsourcing market, 2018 - 2030 (USD Million)
6.3 Europe
6.3.1 Europe medical affairs outsourcing market, 2018 - 2030 (USD Million)
6.3.2 UK
6.3.2.1 UK medical affairs outsourcing market, 2018 - 2030 (USD Million)
6.3.3 Germany
6.3.3.1 Germany medical affairs outsourcing market, 2018 - 2030 (USD Million)
6.3.4 France
6.3.4.1 France medical affairs outsourcing market, 2018 - 2030 (USD Million)
6.3.5 Italy
6.3.5.1 Italy medical affairs outsourcing market, 2018 - 2030 (USD Million)
6.3.6 Spain
6.3.6.1 Spain medical affairs outsourcing market, 2018 - 2030 (USD Million)
6.3.7 Sweden
6.3.7.1 Sweden medical affairs outsourcing market, 2018 - 2030 (USD Million)
6.3.8 Denmark
6.3.8.1 Denmark medical affairs outsourcing market, 2018 - 2030 (USD Million)
6.3.9 Norway
6.3.9.1 Norway medical affairs outsourcing market, 2018 - 2030 (USD Million)
6.4 Asia Pacific
6.4.1 Asia Pacific medical affairs outsourcing market, 2018 - 2030 (USD Million)
6.4.2 China
6.4.2.1 China medical affairs outsourcing market, 2018 - 2030 (USD Million)
6.4.3 India
6.4.3.1 India medical affairs outsourcing market, 2018 - 2030 (USD Million)
6.4.4 Japan
6.4.4.1 Japan medical affairs outsourcing market, 2018 - 2030 (USD Million)
6.4.5 Australia
6.4.5.1 Australia medical affairs outsourcing market, 2018 - 2030 (USD Million)
6.4.6 South Korea
6.4.6.1 South Korea medical affairs outsourcing market, 2018 - 2030 (USD Million)
6.4.7 Thailand
6.4.7.1 Thailand medical affairs outsourcing market, 2018 - 2030 (USD Million)
6.5 Latin America
6.5.1 Latin America medical affairs outsourcing market, 2018 - 2030 (USD Million)
6.5.2 Brazil
6.5.2.1 Brazil medical affairs outsourcing market, 2018 - 2030 (USD Million)
6.5.3 Mexico
6.5.3.1 Mexico medical affairs outsourcing market, 2018 - 2030 (USD Million)
6.5.4 Argentina
6.5.4.1 Argentina medical affairs outsourcing market, 2018 - 2030 (USD Million)
6.6 MEA
6.6.1 MEA medical affairs outsourcing market, 2018 - 2030 (USD Million)
6.6.2 South Africa
6.6.2.1 South Africa medical affairs outsourcing market, 2018 - 2030 (USD Million)
6.6.3 Saudi Arabia
6.6.3.1 Saudi Arabia medical affairs outsourcing market, 2018 - 2030 (USD Million)
6.6.4 UAE
6.6.4.1 UAE medical affairs outsourcing market, 2018 - 2030 (USD Million)
6.6.5 Kuwait
6.6.5.1 Kuwait medical affairs outsourcing market, 2018 - 2030 (USD Million)
Chapter 7 Company Profiles
7.1 Company Profiles
7.2 ICON plc
7.2.1 Company overview
7.2.2 Financial performance
7.2.3 Service benchmarking
7.2.4 Strategic initiatives
7.3 IQVIA
7.3.1 Company overview
7.3.2 Financial performance
7.3.3 Service benchmarking
7.3.4 Strategic initiatives
7.4 THE MEDICAL AFFAIRS COMPANY
7.4.1 Company overview
7.4.2 Financial performance
7.4.3 Service benchmarking
7.4.4 Strategic initiatives
7.5 Syneos Health
7.5.1 Company overview
7.5.2 Financial performance
7.5.3 Service benchmarking
7.5.4 Strategic initiatives
7.6 Thermo Fischer Scientific Inc. (PPD)
7.6.1 Company overview
7.6.2 Financial performance
7.6.3 Service benchmarking
7.6.4 Strategic initiatives
7.7 Ashfield Healthcare
7.7.1 Company overview
7.7.2 Financial performance
7.7.3 Service benchmarking
7.7.4 Strategic initiatives
7.8 ZEINCRO Group
7.8.1 Company overview
7.8.2 Financial performance
7.8.3 Service benchmarking
7.8.4 Strategic initiatives
7.9 Wuxi AppTec
7.9.1 Company overview
7.9.2 Financial performance
7.9.3 Service benchmarking
7.9.4 Strategic initiatives
7.10 SGS SA
7.10.1 Company overview
7.10.2 Financial performance
7.10.3 Service benchmarking
7.10.4 Strategic initiatives
7.11 Indegene
7.11.1 Company overview
7.11.2 Financial Performance
7.11.3 Service benchmarking
7.11.4 Strategic initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Mergers & Acquisitions
Table 4 Collaboration
Table 5 Product launch
List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 QFD modeling for market share assessment
Fig. 6 Market formulation & validation
Fig. 7 Commodity flow analysis
Fig. 8 Volume price analysis
Fig. 9 Medical affairs outsourcing market snapshot (2022)
Fig. 10 Medical affairs outsourcing market segmentation
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Penetration & growth prospect mapping
Fig. 14 Market driver relevance analysis (Current & future impact)
Fig. 15 Market restraint relevance analysis (Current & future impact)
Fig. 16 Porter’s five forces analysis
Fig. 17 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 18 Medical affairs outsourcing market services outlook: Segment dashboard
Fig. 19 Medical affairs outsourcing market: Services movement analysis
Fig. 20 Medical writing & publishing market, 2018 - 2030 (USD Million)
Fig. 21 Medical monitoring market, 2018 - 2030 (USD Million)
Fig. 22 Medical science liaisons (MSLs) market, 2018 - 2030 (USD Million)
Fig. 23 Medical information market, 2018 - 2030 (USD Million)
Fig. 24 Others market, 2018 - 2030 (USD Million)
Fig. 25 Medical affairs outsourcing market industry outlook: Segment dashboard
Fig. 26 Medical affairs outsourcing market: Industry movement analysis
Fig. 27 Pharmaceutical market, 2018 - 2030 (USD Million)
Fig. 28 Biopharmaceutical market, 2018 - 2030 (USD Million)
Fig. 29 Medical devices market, 2018 - 2030 (USD Million)
Fig. 30 Therapeutic medical devices market, 2018 - 2030 (USD Million)
Fig. 31 Diagnostic medical devices market, 2018 - 2030 (USD Million)
Fig. 32 Regional market: Key takeaways
Fig. 33 Regional outlook, 2022 & 2030
Fig. 34 North America market, 2018 - 2030 (USD Million)
Fig. 35 U.S. market, 2018 - 2030 (USD Million)
Fig. 36 Canada market, 2018 - 2030 (USD Million)
Fig. 37 Europe market, 2018 - 2030 (USD Million)
Fig. 38 UK market, 2018 - 2030 (USD Million)
Fig. 39 Germany market, 2018 - 2030 (USD Million)
Fig. 40 France market, 2018 - 2030 (USD Million)
Fig. 41 Italy market, 2018 - 2030 (USD Million)
Fig. 42 Spain market, 2018 - 2030 (USD Million)
Fig. 43 Asia Pacific market, 2018 - 2030 (USD Million)
Fig. 44 China market, 2018 - 2030 (USD Million)
Fig. 45 India market, 2018 - 2030 (USD Million)
Fig. 46 Japan market, 2018 - 2030 (USD Million)
Fig. 47 Australia market, 2018 - 2030 (USD Million)
Fig. 48 South Korea market, 2018 - 2030 (USD Million)
Fig. 49 Latin America market, 2018 - 2030 (USD Million)
Fig. 50 Brazil market, 2018 - 2030 (USD Million)
Fig. 51 Mexico market, 2018 - 2030 (USD Million)
Fig. 52 Argentina market, 2018 - 2030 (USD Million)
Fig. 53 MEA market, 2018 - 2030 (USD Million)
Fig. 54 South Africa market, 2018 - 2030 (USD Million)
Fig. 55 Saudi Arabia market, 2018 - 2030 (USD Million)
Fig. 56 UAE market, 2018 - 2030 (USD Million)
Companies Mentioned
- ICON plc
- IQVIA
- THE MEDICAL AFFAIRS COMPANY
- Syneos Health
- Thermo Fischer Scientific Inc. (PPD)
- Ashfield Healthcare
- ZEINCRO Group
- Wuxi AppTec
- SGS SA
- Indegene
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 120 |
| Published | February 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 1.7 Billion |
| Forecasted Market Value ( USD | $ 4.6 Billion |
| Compound Annual Growth Rate | 13.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
